ASX - By Stock
|
PIQ |
Re:
Ann: Endometriosis clinical validation study readout positive
|
|
clio
|
8 |
3.8K |
6 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
8
|
3.8K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
9 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
67
|
34K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
67
|
34K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
4 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
67
|
34K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Study shows PromarkerD also predicts late-stage renal issues
|
|
clio
|
21 |
8.2K |
8 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
21
|
8.2K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Study shows PromarkerD also predicts late-stage renal issues
|
|
clio
|
21 |
8.2K |
3 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
21
|
8.2K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
U.S. Task Force to consider routine kidney disease screening as new drugs available
|
|
clio
|
4 |
1.8K |
7 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
4
|
1.8K
|
7
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
67
|
34K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
67
|
34K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
67
|
34K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
2 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
67
|
34K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
2 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
67
|
34K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics awarded $400,000 funding to support manufacturing
|
|
clio
|
14 |
6.1K |
0 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
14
|
6.1K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics awarded $400,000 funding to support manufacturing
|
|
clio
|
14 |
6.1K |
0 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
14
|
6.1K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods
|
|
clio
|
67 |
34K |
9 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
67
|
34K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: March 2022 Quarterly Activities Report and Appendix 4C
|
|
clio
|
8 |
3.6K |
3 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
8
|
3.6K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Closes Final Clinical Trial Site
|
|
clio
|
8 |
4.0K |
11 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
8
|
4.0K
|
11
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: March 2022 Quarterly Activities Report and Appendix 4C
|
|
clio
|
8 |
3.6K |
0 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
8
|
3.6K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Presentation
|
|
clio
|
36 |
17K |
6 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
36
|
17K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Presentation
|
|
clio
|
36 |
17K |
7 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
36
|
17K
|
7
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY Presentation at PAC Partners Healthcare Conference
|
|
clio
|
2 |
1.2K |
11 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
2
|
1.2K
|
11
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Presentation
|
|
clio
|
36 |
17K |
4 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
36
|
17K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Webinar Presentation
|
|
clio
|
20 |
9.9K |
3 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
20
|
9.9K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Webinar Presentation
|
|
clio
|
20 |
9.9K |
9 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
20
|
9.9K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
AGM Share Price Guess
|
|
clio
|
25 |
11K |
0 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
25
|
11K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Wake up ASX market
|
|
clio
|
14 |
7.9K |
0 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
14
|
7.9K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
AGM Share Price Guess
|
|
clio
|
25 |
11K |
8 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
25
|
11K
|
8
|
|
ASX - By Stock
|
RHY |
Re:
AGM Share Price Guess
|
|
clio
|
25 |
11K |
3 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
25
|
11K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Webinar Presentation
|
|
clio
|
20 |
9.9K |
3 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
20
|
9.9K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Biosciences - Investor Webinar Presentation
|
|
clio
|
20 |
9.9K |
9 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
20
|
9.9K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appointment of New Company Secretary and General Counsel
|
|
clio
|
2 |
1.1K |
4 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
2
|
1.1K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Maintains Ongoing ISO13485 Certification
|
|
clio
|
46 |
14K |
3 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
46
|
14K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Maintains Ongoing ISO13485 Certification
|
|
clio
|
46 |
14K |
3 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
46
|
14K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
clio
|
27 |
11K |
5 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
27
|
11K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
clio
|
27 |
11K |
1 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
27
|
11K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
clio
|
27 |
11K |
4 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
27
|
11K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands CE Mark Registration for ColoSTAT
|
|
clio
|
36 |
13K |
2 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
36
|
13K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands CE Mark Registration for ColoSTAT
|
|
clio
|
36 |
13K |
1 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
36
|
13K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands CE Mark Registration for ColoSTAT
|
|
clio
|
36 |
13K |
2 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
36
|
13K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Expands CE Mark Registration for ColoSTAT
|
|
clio
|
36 |
13K |
5 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
36
|
13K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY Platform Technology Targets Five Cancers
|
|
clio
|
6 |
2.7K |
5 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
6
|
2.7K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
clio
|
66 |
18K |
1 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
66
|
18K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
clio
|
66 |
18K |
0 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
66
|
18K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
clio
|
66 |
18K |
8 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
66
|
18K
|
8
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Board and Management Restructure
|
|
clio
|
3 |
1.2K |
5 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
3
|
1.2K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
clio
|
66 |
18K |
1 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
66
|
18K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
clio
|
66 |
18K |
2 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
66
|
18K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
clio
|
66 |
18K |
10 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
66
|
18K
|
10
|
|
ASX - By Stock
|
RHY |
Re:
Ann: CE Mark Granted for ColoSTAT
|
|
clio
|
66 |
18K |
8 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
66
|
18K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: FDA advises regulatory pathway for PromarkerD in US
|
|
clio
|
50 |
16K |
3 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
50
|
16K
|
3
|
|